WE Communications Lands Horizon Pharma

The agency will help the Irish company roll out an eye-disease treatment

Thomas Moore, PRWeek, Feb. 19, 2019

Dublin-based Horizon Pharma has chosen WE Communications as its PR partner to roll out an eye-disease treatment.

The firm was signed on February 1 after it won the one-year contract in a competitive search, according to an agency spokesperson. Financial details or details about the search process were not disclosed. There was no incumbent agency on the account, which is focused on a new treatment for active thyroid eye disease.

WE also said that it hired Christina Corso last month as an SVP focused on healthcare comms. 

Read more in prweek